StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Earnings

Filana Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.22
-$0.22 a year earlier
Latest guidance
Raised
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Filana Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open––-$0.22Release
Q2 FY2026ended Jun 30, 2026Jul 29, 2026before the open––-$0.18Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open––-$0.21Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026before the open––-$0.26Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open––-$0.22Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open––-$0.92Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open––-$0.48Release
Q4 FY2024ended Dec 31, 2024Mar 3, 2025before the open––-$0.57Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open––-$0.58Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open––$0.13Release
Q1 FY2024ended Mar 31, 2024May 10, 2024after the close––-$0.43Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Filana Therapeutics's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
cash and cash equivalentsFY2026$38.00M – $42.00M–RaisedNov 5, 2026
net cash use in operationsFY2026$14.00M – $17.00M–NewMar 12, 2026
Net cash used in operationsFY2026$11.00M – $15.00M$11.00M – $15.00MLoweredNov 5, 2026
unrestricted cashFY2026$36.00M – $40.00M–RaisedJul 29, 2026

Guidance history

Every forecast Filana Therapeutics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026cash and cash equivalentsFY2026$38.00M – $42.00MRaised
Nov 5, 2026Net cash used in operationsFY2026$11.00M – $15.00MLowered
Jul 29, 2026unrestricted cashFY2026$36.00M – $40.00MRaised
Jul 29, 2026Net cash used in operationsFY2026$11.00M – $15.00MLowered
Mar 12, 2026net cash use in operationsFY2026$14.00M – $17.00MNew
Nov 12, 2025incremental cash useQ4 FY2025$10.00M – $14.00MNew
Nov 12, 2025cashFY2025$92.00M – $96.00MRaised
Aug 14, 2025Net cash used in operationsFY2025$47.00M – $51.00MRaised
Aug 14, 2025cashFY2025$61.00M – $65.00MNew
May 8, 2025Net cash used in operationsFY2025$16.00M – $20.00MReaffirmed
Mar 3, 2025Net cash use in operationsFY2025$16.00M – $20.00MNew
Nov 7, 2024Net cash used in operationsFY2024$40.00M – $50.00MRaised
Nov 7, 2024cash and cash equivalentsQ4 FY2024$117.00M – $127.00MNew
May 10, 2024Net cash use in operationsFY2024$35.00M – $45.00MReaffirmed
Feb 28, 2024Cash use for operationsFY2024$35.00M – $45.00MNew
Nov 7, 2023Net cash use in operationsFY2023$40.00M – $50.00MReaffirmed
Aug 3, 2023Net cash use in operationsFY2023$40.00M – $50.00MRaised
May 1, 2023net cash use in operationsFY2023$30.00M – $40.00MLowered
Feb 28, 2023Net cash use for operationsFY2023$45.00M – $50.00MNew
Nov 7, 2022Net cash use in operationsFY2022$80.00M – $90.00MReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Filana Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. Results
  5. Results
  6. Results
  7. Update
  8. Update
  9. Results
  10. Update
  11. Update
  12. Results
  13. Update
  14. Update
  15. Results

See a number that looks wrong?